Interpersonal Psychotherapy-Based Counseling for Hemodialysis Patients: Effect on Adjustment and Depression
The Effect of Relationship Psychotherapy-Based Counselling Applied to Individuals Receiving Hemodialysis Adjusment to Illness and Depression Levels: A Randomised Controlled Study
1 other identifier
interventional
48
1 country
1
Brief Summary
The aim of this clinical study is to examine the effect of interpersonal psychotherapy-based counseling on adjustment to illness and depression levels in individuals receiving hemodialysis treatment. The main questions this study aims to answer are: Does interpersonal psychotherapy-based counseling improve the adjustment to illness in individuals receiving hemodialysis treatment? Does interpersonal psychotherapy-based counseling reduce depressive symptoms in individuals receiving hemodialysis treatment? The researchers will compare interpersonal psychotherapy-based counseling with routine care to determine its effectiveness in individuals undergoing hemodialysis treatment. Participants: For eight weeks, participants will receive either routine care or interpersonal psychotherapy-based counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2025
CompletedSeptember 17, 2025
February 1, 2025
4 months
February 17, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adaptation to Chronic Diseases Scale
The Adaptation to Chronic Diseases Scale was developed by Atik and Karatepe (2016) to assess the level of adaptation to the disease of individuals diagnosed with chronic diseases (heart, lung and kidney diseases, diabetes, etc.). In the scale, situations including beliefs, attitudes and behaviors experienced by individuals diagnosed with chronic diseases during the disease are specified. The scale consists of 5-point Likert type and 25 items (56). The scale has 3 sub-dimensions as Physical, Social and Psychological Adjustment. Physical Adjustment sub-dimension consists of 1st, 9th, 10th, 13th, 16th, 18th, 22-24th items, Social Adjustment sub-dimension consists of 2nd, 3rd, 5th, 7th, 17th, 19th and 25th items, Psychological Adjustment sub-dimension consists of 4th, 6th, 8th, 11th, 12th, 20th and 21st items. A maximum score of 55 and a minimum score of 11 can be obtained from the Physical Adjustment sub-dimension, a maximum score of 35 and a minimum score of 7 from the Social Adjustment
five mounths
Secondary Outcomes (1)
Beck Depression Scale
five mounths
Study Arms (2)
IPT Group
EXPERIMENTALInterpersonal psychotherapy-based counseling will be applied to indivuduals with receiving hemodialysis for 8 weeks
Control Group
NO INTERVENTIONParticipants in this group will receive routine care
Interventions
The first data from the individuals in the experimental and control groups will be collected after the first interview. Data will be collected from the individuals to whom interpersonal relationship therapy techniques are applied after the 8th session by face-to-face interviews. In addition, if the individuals in the experimental group have questions about psychotherapy, they will be answered. The control group will be verbally informed with the data collection form and chronic disease adaptation and depression scales and will continue to receive routine care. Data will be collected by face-to-face interviews with the control group after the first interview and 8 weeks later when they come to the dialysis center. Follow-up data of the participants will be collected again at the 3rd month after the last interview.
Eligibility Criteria
You may qualify if:
- 18 years of age or older,
- Hemodialysis treatment for at least 6 months,
- Having no problem communicating in Turkish,
- No hearing problems and cognitive impairment,
- Openness to cooperation,
- Not diagnosed with major depression according to DSM-V and ICD-11,
- Not having an additional mental disorder,
- Not receiving any therapy or treatment,
- Receiving hemodialysis treatment at the center 3 days a week,
- Do not take care of yourself,
- Scoring 10 and above on the Beck Depression Inventory (scores of 10 and above indicate that the participant has depressive symptoms)
- Patients who voluntarily agree to participate in the study will be included.
You may not qualify if:
- \- Having a neurological or psychiatric illness that may interfere with reading and understanding the data collection tools,
- Have received or are receiving any therapy or treatment,
- A score of 10 or less on the Beck Depression Inventory,
- Having problems in speaking/understanding Turkish,
- Changing cities during research,
- Don't want to leave the research,
- Receiving a psychiatric diagnosis during research,
- Starting therapy or treatment during the research,
- Hospitalization during research,
- Failure to attend the treatment for 2 consecutive sessions,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başkent University
Ankara, Turkey (Türkiye)
Related Publications (22)
Stuart S, Schultz J, Molina AP, Siber-Sanderowitz S. Interpersonal Psychotherapy: A Review of Theory, History, and Evidence of Efficacy. Psychodyn Psychiatry. 2024 Sep;52(3):370-407. doi: 10.1521/pdps.2024.52.3.370.
PMID: 39254940BACKGROUNDSummers KM, Martin KE, Watson K. Impact and clinical management of depression in patients with coronary artery disease. Pharmacotherapy. 2010 Mar;30(3):304-22. doi: 10.1592/phco.30.3.304.
PMID: 20180613BACKGROUNDXu H, Koszycki D. Interpersonal Psychotherapy for Late-life Depression and its Potential Application in China. Neuropsychiatr Dis Treat. 2020 Aug 7;16:1919-1928. doi: 10.2147/NDT.S248027. eCollection 2020.
PMID: 32821108BACKGROUNDKaram AM, Fitzsimmons-Craft EE, Tanofsky-Kraff M, Wilfley DE. Interpersonal Psychotherapy and the Treatment of Eating Disorders. Psychiatr Clin North Am. 2019 Jun;42(2):205-218. doi: 10.1016/j.psc.2019.01.003.
PMID: 31046923BACKGROUNDCuijpers P, Donker T, Weissman MM, Ravitz P, Cristea IA. Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis. Am J Psychiatry. 2016 Jul 1;173(7):680-7. doi: 10.1176/appi.ajp.2015.15091141. Epub 2016 Apr 1.
PMID: 27032627BACKGROUNDRavitz P, Watson P, Lawson A, Constantino MJ, Bernecker S, Park J, Swartz HA. Interpersonal Psychotherapy: A Scoping Review and Historical Perspective (1974-2017). Harv Rev Psychiatry. 2019 May/Jun;27(3):165-180. doi: 10.1097/HRP.0000000000000219.
PMID: 30883446BACKGROUNDPu J, Zhou X, Liu L, Zhang Y, Yang L, Yuan S, Zhang H, Han Y, Zou D, Xie P. Efficacy and acceptability of interpersonal psychotherapy for depression in adolescents: A meta-analysis of randomized controlled trials. Psychiatry Res. 2017 Jul;253:226-232. doi: 10.1016/j.psychres.2017.03.023. Epub 2017 Mar 16.
PMID: 28391140BACKGROUNDPoleshuck EL, Talbot NE, Zlotnick C, Gamble SA, Liu X, Tu X, Giles DE. Interpersonal psychotherapy for women with comorbid depression and chronic pain. J Nerv Ment Dis. 2010 Aug;198(8):597-600. doi: 10.1097/NMD.0b013e3181ea4d3d.
PMID: 20699727BACKGROUNDPalmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013 Jul;84(1):179-91. doi: 10.1038/ki.2013.77. Epub 2013 Mar 13.
PMID: 23486521BACKGROUNDTian N, Chen N, Li PK. Depression in dialysis. Curr Opin Nephrol Hypertens. 2021 Nov 1;30(6):600-612. doi: 10.1097/MNH.0000000000000741.
PMID: 34456238BACKGROUNDGerogianni G, Kouzoupis A, Grapsa E. A holistic approach to factors affecting depression in haemodialysis patients. Int Urol Nephrol. 2018 Aug;50(8):1467-1476. doi: 10.1007/s11255-018-1891-0. Epub 2018 May 19.
PMID: 29779116BACKGROUNDFrasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberte MA, Abramson BL, Lambert J, Gravel G, Lesperance F. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE). Psychosom Med. 2006 Jan-Feb;68(1):87-93. doi: 10.1097/01.psy.0000195833.68482.27.
PMID: 16449416BACKGROUNDBelay W, Kaba M, Labisso WL, Tigeneh W, Sahile Z, Zergaw A, Ejigu A, Baheretibeb Y, Gufue ZH, Haileselassie W. The effect of interpersonal psychotherapy on quality of life among breast cancer patients with common mental health disorder: a randomized control trial at Tikur Anbessa Specialized Hospital. Support Care Cancer. 2022 Jan;30(1):965-972. doi: 10.1007/s00520-021-06508-y. Epub 2021 Aug 25.
PMID: 34432169BACKGROUNDYator O, Kagoya M, Khasakhala L, John-Stewart G, Kumar M. Task-sharing and piloting WHO group interpersonal psychotherapy (IPT-G) for adolescent mothers living with HIV in Nairobi primary health care centers: a process paper. AIDS Care. 2021 Jul;33(7):873-878. doi: 10.1080/09540121.2020.1801981. Epub 2020 Aug 11.
PMID: 32781831BACKGROUNDHedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006 May;69(9):1662-8. doi: 10.1038/sj.ki.5000308.
PMID: 16598203BACKGROUNDÇınar, S. (2009). Hemodiyaliz hastalarında psikososyal uyum ve etkileyen faktörlerin belirlenmesi. Nefroloji Hemşireliği Dergisi, 6(1-2), 22-28.
BACKGROUNDDavison SN. Personalized Approach and Precision Medicine in Supportive and End-of-Life Care for Patients With Advanced and End-Stage Kidney Disease. Semin Nephrol. 2018 Jul;38(4):336-345. doi: 10.1016/j.semnephrol.2018.05.004.
PMID: 30082054BACKGROUNDSchulman-Green D, Jaser S, Martin F, Alonzo A, Grey M, McCorkle R, Redeker NS, Reynolds N, Whittemore R. Processes of self-management in chronic illness. J Nurs Scholarsh. 2012 Jun;44(2):136-44. doi: 10.1111/j.1547-5069.2012.01444.x. Epub 2012 May 2.
PMID: 22551013BACKGROUNDKacaroglu Vicdan A, Gulseven Karabacak B. Effect of Treatment Education Based on the Roy Adaptation Model on Adjustment of Hemodialysis Patients. Clin Nurse Spec. 2016 Jul-Aug;30(4):E1-E13. doi: 10.1097/NUR.0000000000000215.
PMID: 27309790BACKGROUNDWebster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017 Mar 25;389(10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23.
PMID: 27887750BACKGROUNDRomagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ. Chronic kidney disease. Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88.
PMID: 29168475BACKGROUNDKalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021 Aug 28;398(10302):786-802. doi: 10.1016/S0140-6736(21)00519-5. Epub 2021 Jun 24.
PMID: 34175022BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- In this study, participants will be randomly assigned to intervention and control groups. As a blinding method, it will be arranged so that the participants and the people responsible for data analysis who will make the evaluations will not know which group the participants are in (single-blind or double-blind design). Participants may know their groups due to the intervention content, but evaluations will be made with objective scales so as not to affect the study results.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
February 17, 2025
First Posted
February 21, 2025
Study Start
March 1, 2025
Primary Completion
July 1, 2025
Study Completion
September 5, 2025
Last Updated
September 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share